Found 7 matching trials
This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C PHASE2 The objective of this trial is to investigate tolerability, safety, pharmac...
Show More Location
1241.25.002 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects PHASE1 The purpose of this trial is to investigate the effect of food with differe...
Show More Location
1241.44.49001 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3 PHASE2 To assess the pharmacokenetic characteristics of 600 mg BID BI 207127 / 120...
Show More Location
1241.30.10003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection PHASE2 The substances BI 201335 and BI 207127 are being developed for the treatmen...
Show More Location
1241.21.0003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female Subjects PHASE1 The objective of the current trial is to evaluate safety, tolerability and ...
Show More Location
1241.35.1 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers PHASE1 The aim of the study is to evaluate safety, tolerability and pharmacokineti...
Show More Location
1241.8.8201 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients PHASE1 The main purpose of this clinical trial with BI 207127 is to see the effect...
Show More Location
1241.7.3307A CHU de Grenoble
Learn More & Join Trial